About PanAmerican Clinical Research S.A.de C.V. Guadalajara
"PanAmerican sirve a patrocinadores farmacéuticos, CRO, proveedores de ensayos virtuales y organizadores de salud global en América del Sur, Central y Norte. Somos un centro de investigación médica, que genera datos de calidad a través de un proceso centrado en el paciente y la comunidad. Contamos con un equipo de médicos y enfermeros dedicados a la investigación clínica."
Clinical Trials at PanAmerican Clinical Research S.A.de C.V. Guadalajara
During the past decade, PanAmerican Clinical Research S.A.de C.V. Guadalajara conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "PanAmerican Clinical Research S.A.de C.V. Guadalajara"
#1 collaborator was "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at PanAmerican Clinical Research S.A.de C.V. Guadalajara
According to Clinical.Site data, the most researched conditions in "PanAmerican Clinical Research S.A.de C.V. Guadalajara" are
"COVID-19" (2 trials), "Migraine" (2 trials), "Chronic Migraine" (1 trials), "Crohn's Disease" (1 trials) and "Episodic Migraine" (1 trials). Many other conditions were trialed in "PanAmerican Clinical Research S.A.de C.V. Guadalajara" in a lesser frequency.
Clinical Trials Intervention Types at PanAmerican Clinical Research S.A.de C.V. Guadalajara
Most popular intervention types in "PanAmerican Clinical Research S.A.de C.V. Guadalajara" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Galcanezumab" (2 trials), "Lasmiditan" (2 trials), "Mirikizumab" (1 trials) and "RO7496998" (1 trials). Other intervention names were less common.
Clinical Trials Genders at PanAmerican Clinical Research S.A.de C.V. Guadalajara
The vast majority of trials in "PanAmerican Clinical Research S.A.de C.V. Guadalajara" are
7 trials for "All" genders.
Clinical Trials Status at PanAmerican Clinical Research S.A.de C.V. Guadalajara
Currently, there are NaN active trials in "PanAmerican Clinical Research S.A.de C.V. Guadalajara".
undefined are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in PanAmerican Clinical Research S.A.de C.V. Guadalajara,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in PanAmerican Clinical Research S.A.de C.V. Guadalajara, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".